The GIBH-HKU Guangdong-Hong Kong Stem Cell and Regenerative Medicine Research Centre (the GIBH-HKU Joint Centre) was officially inaugurated at HKU on August 18, 2011. The former Prime Minister Li Keqiang and the former Hong Kong Chief Executive Donald Tsang unveiled the center at the 100th anniversary celebration of The University of Hong Kong. Its establishment represents a significant collaboration between GIBH and HKU, serving as an important initiative to implement the “Framework Agreement on Hong Kong- Guangdong Cooperation”.
Based on the disciplinary advantages and complementarity of both parties, the two parties have determined since their establishment that they will focus on stem cells and regenerative medicine by using stem cells to obtain functional/therapeutic cells, tissues, and organs for disease modeling and cell therapy. Stem cells and regenerative medicine have become a new generation of medical revolution after drug treatment and surgical treatment, which will pave the way for innovations in the basic science of cell biology, genetics and medicine, and for huge change in social and economic areas as well.
Prof. Chen Jiekai is currently the Co-Director of the GIBH-HKU Joint Centre from GIBH side, and is also the Director of the Cell Lineage and Development Research Center, Executive Deputy Director of the Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine. He has several National and CAS talent title or academic positions, including the recipient of the National Science Fund for Distinguished Young Scholars.
Other GIBH team faculty members include Prof. Peng Guangdun, Prof. Li Peng, and Prof. Lai Liangxue, Prof. Cai Chenleng, Prof. Pan Guangjin, and Prof Wu Donghai.
Prof. Tse Hung-Fat is the Co-Director of the GIBH-HKU Joint Centre from HKU side, and is also the Chairperson of the Department of Medicine, School of Clinical Medicine, Li Ka-Shing Faculty of Medicine, HKU, the Chief of the Cardiology Division, Honorary Consultant and Chief of Service of the Department of Medicine at Queen Mary Hospital.
The HKU team mainly comes from the cardiovascular professional team of Queen Mary Hospital. Among them are Prof. YIU Kai-Hang, and Prof. SIU Chung-Wah, who are both well-known cardiologists with rich clinical experience.
Other team faculty members include Prof. Liu Pengtao, Prof. Xu Aimin and Prof. Ralf Jauch. Prof. Liu Pengtao is the Director of Centre for Translational Stem Cell Biology.